• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).

作者信息

Farmakis Ioannis T, Karyofyllis Panagiotis, Frantzeskaki Frantzeska, Demerouti Eftychia, Anthi Anastasia, Arvanitaki Alexandra, Pitsiou Georgia, Naka Katerina K, Bechlioulis Aris, Thomaidi Adina, Avgeropoulou Aikaterini, Brili Styliani, Mitrouska Ioanna, Manginas Athanasios, Orfanos Stylianos E, Tsangaris Iraklis, Giannakoulas George

机构信息

Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.

Cardiology-Pediatric Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.

出版信息

Hellenic J Cardiol. 2022 Mar-Apr;64:93-96. doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26.

DOI:10.1016/j.hjc.2021.10.002
PMID:34843997
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8619882/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7ef/8619882/85031060f751/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7ef/8619882/85031060f751/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7ef/8619882/85031060f751/gr1_lrg.jpg

相似文献

1
Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).肺动脉高压和慢性血栓栓塞性肺动脉高压患者中新型冠状病毒肺炎的发病率及预后：来自希腊肺动脉高压注册研究（HOPE）的数据
Hellenic J Cardiol. 2022 Mar-Apr;64:93-96. doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26.
2
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care.基于调查的肺动脉高压或慢性血栓栓塞性肺动脉高压患者 COVID-19 发病率和结局的估计及其对治疗过程的影响。
Ann Am Thorac Soc. 2020 Dec;17(12):1576-1582. doi: 10.1513/AnnalsATS.202005-521OC.
3
ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy.体外膜肺氧合在肺动脉高压和慢性血栓栓塞性肺动脉高压中作为治疗桥梁的应用
Kardiol Pol. 2023;81(5):500-504. doi: 10.33963/KP.a2023.0055. Epub 2023 Mar 5.
4
[Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension].[有症状和无症状慢性血栓栓塞性肺动脉高压的发病率]
Arch Bronconeumol. 2010 Dec;46(12):628-33. doi: 10.1016/j.arbres.2010.07.012.
5
First data from Latvian chronic thromboembolic pulmonary hypertension registry.来自拉脱维亚慢性血栓栓塞性肺动脉高压登记处的首批数据。
Eur J Intern Med. 2016 Jul;32:e23-4. doi: 10.1016/j.ejim.2016.01.017. Epub 2016 Feb 4.
6
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.慢性血栓栓塞性肺动脉高压患者的长期预后：国际前瞻性登记研究结果。
Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.
7
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2021 according to the new definition.2021年拉脱维亚根据新定义的肺动脉高压和慢性血栓栓塞性肺动脉高压发病率。
Eur J Intern Med. 2022 Dec;106:152-153. doi: 10.1016/j.ejim.2022.08.030. Epub 2022 Aug 30.
8
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis.急性肺栓塞后慢性血栓栓塞性肺动脉高压的发病率：一项更新的系统评价和荟萃分析。
Eur Respir J. 2023 Jul 7;62(1). doi: 10.1183/13993003.00449-2023. Print 2023 Jul.
9
Epidemiology and management of chronic thromboembolic pulmonary hypertension: experience from two expert centers.慢性血栓栓塞性肺动脉高压的流行病学和管理：来自两个专家中心的经验。
Hellenic J Cardiol. 2018 Jan-Feb;59(1):16-23. doi: 10.1016/j.hjc.2017.05.005. Epub 2017 May 17.
10
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry.球囊肺动脉血管成形术治疗慢性血栓栓塞性肺动脉高压：一项多中心注册研究的结果
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). doi: 10.1161/CIRCOUTCOMES.117.004029.

引用本文的文献

1
The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.COVID-19 感染对严重慢性肺动脉高压患者的影响：来自单一转诊中心的前瞻性研究。
Medicina (Kaunas). 2024 Apr 30;60(5):750. doi: 10.3390/medicina60050750.
2
Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.肺动脉高压和慢性血栓栓塞性肺动脉高压患者感染新冠病毒康复后出现的长期新冠综合征。
Pulm Circ. 2023 May 31;13(2):e12244. doi: 10.1002/pul2.12244. eCollection 2023 Apr.
3
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis.
肺动脉高压患者 COVID-19 相关死亡率的趋势：COMPERA 分析。
Eur Respir J. 2023 Apr 27;61(4). doi: 10.1183/13993003.02440-2022. Print 2023 Apr.
4
Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.预测肺动脉高压患者 1 年内住院风险。
Adv Ther. 2023 May;40(5):2481-2492. doi: 10.1007/s12325-023-02501-5. Epub 2023 Apr 6.
5
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.COVID-19 患者的肺动脉高压管理。
Heart Fail Clin. 2023 Jan;19(1):107-114. doi: 10.1016/j.hfc.2022.07.003. Epub 2022 Aug 10.
6
The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?2019冠状病毒病大流行对肺动脉高压的影响：我们学到了什么？
Pulm Circ. 2022 Oct 1;12(4):e12142. doi: 10.1002/pul2.12142. eCollection 2022 Oct.
7
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.意大利的 COVID-19 大流行与肺动脉高压：适应、结果和宝贵经验教训。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.00796-2022. Print 2022 Oct.